Allspring Global Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-42
Closed -$1.77K 2929
2023
Q2
$1.77K Sell
42
-89,650
-100% -$3.62M ﹤0.01% 2636
2023
Q1
$3.19M Sell
89,692
-198,846
-69% -$7.22M 0.01% 1114
2022
Q4
$10.6M Buy
288,538
+272,524
+1,702% +$10.8M 0.02% 768
2022
Q3
$755K Buy
16,014
+7,734
+93% +$500K ﹤0.01% 1490
2022
Q2
$593K Sell
8,280
-55,399
-87% -$4.05M ﹤0.01% 1542
2022
Q1
$5.15M Sell
63,679
-1,991
-3% -$168K 0.01% 1133
2021
Q4
$6.74M Buy
+65,670
New +$6.31M 0.01% 1074

Other funds holding SYNH

Allspring Global Investments's SYNH Position: Q3 2023 in Review

Allspring Global Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 42 shares — an estimated $1.77K sold.

Allspring Global Investments first reported a position in SYNH in Q4 2021 and held it in 7 quarters. The position peaked at $10.6M in Q4 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Allspring Global Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 42 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.77K.
  • Allspring Global Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • Allspring Global Investments's Syneos Health, Inc. Class A Common Stock position peaked at $10.6M in Q4 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.